These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22521940)

  • 21. The transfemoral approach for cardiac resynchronization therapy.
    Chaggar PS; Skene C; Williams SG
    Europace; 2015 Feb; 17(2):173. PubMed ID: 25488956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
    Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
    JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac resynchronization therapy: state of the art 2013.
    Yu CM; Hayes DL
    Eur Heart J; 2013 May; 34(19):1396-403. PubMed ID: 23355652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
    Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
    Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.
    Zusterzeel R; Selzman KA; Sanders WE; Caños DA; O'Callaghan KM; Carpenter JL; Piña IL; Strauss DG
    JAMA Intern Med; 2014 Aug; 174(8):1340-8. PubMed ID: 25090172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Geometrical and electrical predictors of cardiac resynchronization therapy response.
    Stabile G; Iuliano A; La Rocca V; Solimene F; Fazio R; De Simone A
    Expert Rev Cardiovasc Ther; 2014 Jul; 12(7):873-84. PubMed ID: 24849323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study.
    Auricchio A; Delnoy PP; Butter C; Brachmann J; Van Erven L; Spitzer S; Moccetti T; Seifert M; Markou T; Laszo K; Regoli F;
    Europace; 2014 May; 16(5):681-8. PubMed ID: 24497573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left ventricular endocardial pacing via the interventricular septum for cardiac resynchronization therapy: first report.
    Gamble JH; Bashir Y; Rajappan K; Betts TR
    Heart Rhythm; 2013 Dec; 10(12):1812-4. PubMed ID: 23891954
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial.
    Cleland JG; Freemantle N; Erdmann E; Gras D; Kappenberger L; Tavazzi L; Daubert JC
    Eur J Heart Fail; 2012 Jun; 14(6):628-34. PubMed ID: 22552183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience.
    Kutyifa V; Geller L; Bogyi P; Zima E; Aktas MK; Ozcan EE; Becker D; Nagy VK; Kosztin A; Szilagyi S; Merkely B
    Eur J Heart Fail; 2014 Dec; 16(12):1323-30. PubMed ID: 25379962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy on mortality and risk of defibrillator therapy for ventricular arrhythmias in heart failure patients (from the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region [STARTER] trial).
    Adelstein E; Alam MB; Schwartzman D; Jain S; Marek J; Gorcsan J; Saba S
    Am J Cardiol; 2014 May; 113(9):1518-22. PubMed ID: 24630387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RESPOND-CRT trial.
    Eur Heart J; 2016 Nov; 37(41):3128-3129. PubMed ID: 27838657
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of cardiac resynchronization therapy on left ventricular mass and wall thickness in mild heart failure patients in MADIT-CRT.
    Kutyifa V; Solomon SD; Bourgoun M; Shah AM; Pouleur AC; Knappe D; McNitt S; Wang PJ; Merkely B; Pfeffer M; Moss AJ; Zareba W
    Heart Rhythm; 2013 Mar; 10(3):354-60. PubMed ID: 23174486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indications for cardiac resynchronization therapy.
    O'Brien TM; Schloss EJ; Chung ES
    Cardiol Clin; 2014 May; 32(2):293-8. PubMed ID: 24793804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac resynchronization therapy in mildly symptomatic heart failure: the earlier the better.
    Balmain S; McDonald MA
    Expert Rev Cardiovasc Ther; 2011 Sep; 9(9):1147-53. PubMed ID: 21932957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interventricular conduction time is associated with response to cardiac resynchronization therapy: interventricular electrical delay.
    D'Onofrio A; Botto G; Mantica M; La Rosa C; Occhetta E; Verlato R; Molon G; Ammendola E; Villani GQ; Bongiorni MG; Gelmini GP; Ciardiello C; Dicandia CD
    Int J Cardiol; 2013 Oct; 168(5):5067-8. PubMed ID: 23953259
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
    Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
    Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).
    Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC
    Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.